IBT
TRIL

International Biotechnology Trust’s Trillium Therapeutics Inc. TRIL Stock Holding History

International Biotechnology Trust’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-161,069
Closed -$693K – 68
2017
Q2 		$693K Sell
161,069
-60,778
-27% -$261K 0.26% 56
2017
Q1 		$1.36M Hold
221,847
– – 0.52% 39
2016
Q4 		$1.25M Buy
+221,847
New +$1.25M 0.56% 35